Syra HealthSYRA -3.81%12 EPS without NRI is $-0.03 as of Mar. 2026. GuruFocus rates SYRA with a GF Score™ of 12/100 and a GF Value™ of $0.23 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 513 Healthcare Providers & Services companies, Syra Health ranks better than 77.19% on this metric.
Syra Health's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was $0.02.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.03.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 35.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Syra Health's EPS without NRI or its related term are showing as below:
SYRA'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 35 Med: 35 Max: 35
Current: 35
During the past 6 years, Syra Health's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 35.00% per year. The lowest was 35.00% per year. And the median was 35.00% per year.
SYRA's 3-Year EPS without NRI Growth Rate is ranked better than 77.19% of 513
companies
in the Healthcare Providers & Services industry
Industry Median: 11.6
vs SYRA: 35.00
Syra Health's EPS (Diluted) for the
three
months ended in Mar. 2026 was $0.02.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.03.
Syra Health's EPS (Basic) for the
three
months ended in Mar. 2026 was $0.02.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.03.
Syra Health (OTCPK:SYRA) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Syra Health EPS without NRI Related Terms
Syra Health EPS without NRI Historical Data
* Premium members only.
The historical data trend for Syra Health's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SYRA vs NIVF, BICX, HLYK: EPS without NRI Comparison
For the Medical Care Facilities subindustry, Syra Health's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Syra Health PE Ratio without NRI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Syra Health's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Syra Health's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syra Health (SYRA) has a EPS without NRI of $-0.03 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Syra Health and its competitors. According to the industry distribution chart, Syra Health ranks #117 out of 513 companies in the Healthcare Providers & Services industry, placing it in the top 22.8%.
Is Syra Health's EPS without NRI too high?
Syra Health's current EPS without NRI is $-0.03. Based on the distribution chart, Syra Health ranks #117 out of 513 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Syra Health has a GF Score™ of 12/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Syra Health's EPS without NRI compare to NIVF and BICX?
According to the Healthcare Providers & Services industry distribution chart, Syra Health ranks #117 out of 513 companies for EPS without NRI. This places Syra Health in the top 23% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 11.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.60, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Syra Health and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Syra Health's current EPS without NRI is $-0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syra Health stock overvalued right now?
Based on GuruFocus' analysis, Syra Health (SYRA) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.23, compared to a current price of $0.70 — trading 205.2% above its estimated fair value. The current EPS without NRI is $-0.03. Syra Health's overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Syra Health (SYRA), the current EPS without NRI is $-0.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Syra Health (SYRA) Overvalued in 2026?
Based on GuruFocus' analysis, Syra Health stock appears to be overvalued.
The current stock price of $0.70 is trading 205.2% above its estimated GF Value™ of $0.23.
GuruFocus considers Syra Health to be Significantly Overvalued.
Key valuation signals for SYRA:
EPS without NRI: $-0.03
GF Value™: $0.23 vs. price of $0.70 (205.2% above fair value)
No single metric tells the full story. See the SYRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Syra Health Corp is an integrated healthcare solutions company serving government and commercial healthcare organizations. It delivers end-to-end capabilities across population health, behavioral and mental health, digital health, health education and training, and healthcare workforce development and staffing. The various services offered by the company include Syrenity, a mental health application providing preventative care and interventions for behavioral and mental health conditions; SyraBot, a chatbot offering members access to necessary information via the firm's AI-powered customer support chat system; CarePlus, an electronic medical records solution designed for small to mid-sized healthcare organizations; and patient engagement and education services, among others.
12GF Score
Get the complete analysis for SYRA
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SYRA has been successfully added to your 
